| Jonathan F Mercer, MD | |
|
210 Sunnyview Ln, Suite 106, Kalispell, MT 59901-3135 | |
| (406) 756-1433 | |
| (406) 756-1446 |
| Full Name | Jonathan F Mercer |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 32 Years |
| Location | 210 Sunnyview Ln, Kalispell, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992746192 | NPI | - | NPPES |
| 117538 | Medicaid | MT | |
| 96746 | Other | MT | BLUE CROSS OF MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 10917 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Hospital Of Anaconda | Anaconda, MT | Hospital |
| Kalispell Regional Medical Center | Kalispell, MT | Hospital |
| North Valley Hospital | Whitefish, MT | Hospital |
| Cabinet Peaks Medical Center | Libby, MT | Hospital |
| Entity Name | Community Hospital Of Anaconda |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1205887924 PECOS PAC ID: 8123938974 Enrollment ID: O20030507000045 |
News Archive
About 10 percent of women worldwide suffer from endometriosis, a painful and debilitating disease with inadequate treatments.
Baxter International Inc. and Nycomed today announced the U.S. Food and Drug Administration (FDA) approval of TachoSil (Absorbable Fibrin Sealant Patch) for use as an adjunct to hemostasis in cardiovascular surgery. TachoSil is the first and only adjunctive hemostatic agent available in the U.S. that combines a collagen patch with a coating of human coagulation factors.
SARS-CoV-2 pandemic has highlighted the shortcomings in emergency response globally and has driven a massive demand for in vitro diagnostic testing technologies. In order to address these issues, researchers from the US recently used the new pH dye LAMPShade Violet (LSV) in RT-LAMP. LSV has better visual contrast between high and low pH and a stronger inflection point, both of which enable easy interpretation of results and reduces ambiguity.
Methylphenidate is a drug commonly prescribed for attention deficit hyperactivity disorder (ADHD) in children. The rapid increase in use of the drug over the past few decades has been noted in numerous countries, including Canada.
In light of the recent recommendation of the United States Preventative Task Force (USPTF), the Obesity Action Coalition (OAC) is calling for all employers and insurers to add health insurance coverage of the recommended childhood obesity treatments.
› Verified 7 days ago
| Entity Name | Community Hospital Of Anaconda |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538597703 PECOS PAC ID: 8123938974 Enrollment ID: O20031119000745 |
News Archive
About 10 percent of women worldwide suffer from endometriosis, a painful and debilitating disease with inadequate treatments.
Baxter International Inc. and Nycomed today announced the U.S. Food and Drug Administration (FDA) approval of TachoSil (Absorbable Fibrin Sealant Patch) for use as an adjunct to hemostasis in cardiovascular surgery. TachoSil is the first and only adjunctive hemostatic agent available in the U.S. that combines a collagen patch with a coating of human coagulation factors.
SARS-CoV-2 pandemic has highlighted the shortcomings in emergency response globally and has driven a massive demand for in vitro diagnostic testing technologies. In order to address these issues, researchers from the US recently used the new pH dye LAMPShade Violet (LSV) in RT-LAMP. LSV has better visual contrast between high and low pH and a stronger inflection point, both of which enable easy interpretation of results and reduces ambiguity.
Methylphenidate is a drug commonly prescribed for attention deficit hyperactivity disorder (ADHD) in children. The rapid increase in use of the drug over the past few decades has been noted in numerous countries, including Canada.
In light of the recent recommendation of the United States Preventative Task Force (USPTF), the Obesity Action Coalition (OAC) is calling for all employers and insurers to add health insurance coverage of the recommended childhood obesity treatments.
› Verified 7 days ago
| Entity Name | Flathead Urology, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649300534 PECOS PAC ID: 0345347431 Enrollment ID: O20070524000503 |
News Archive
About 10 percent of women worldwide suffer from endometriosis, a painful and debilitating disease with inadequate treatments.
Baxter International Inc. and Nycomed today announced the U.S. Food and Drug Administration (FDA) approval of TachoSil (Absorbable Fibrin Sealant Patch) for use as an adjunct to hemostasis in cardiovascular surgery. TachoSil is the first and only adjunctive hemostatic agent available in the U.S. that combines a collagen patch with a coating of human coagulation factors.
SARS-CoV-2 pandemic has highlighted the shortcomings in emergency response globally and has driven a massive demand for in vitro diagnostic testing technologies. In order to address these issues, researchers from the US recently used the new pH dye LAMPShade Violet (LSV) in RT-LAMP. LSV has better visual contrast between high and low pH and a stronger inflection point, both of which enable easy interpretation of results and reduces ambiguity.
Methylphenidate is a drug commonly prescribed for attention deficit hyperactivity disorder (ADHD) in children. The rapid increase in use of the drug over the past few decades has been noted in numerous countries, including Canada.
In light of the recent recommendation of the United States Preventative Task Force (USPTF), the Obesity Action Coalition (OAC) is calling for all employers and insurers to add health insurance coverage of the recommended childhood obesity treatments.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan F Mercer, MD 210 Sunnyview Ln, Suite 106, Kalispell, MT 59901-3135 Ph: (406) 756-1433 | Jonathan F Mercer, MD 210 Sunnyview Ln, Suite 106, Kalispell, MT 59901-3135 Ph: (406) 756-1433 |
News Archive
About 10 percent of women worldwide suffer from endometriosis, a painful and debilitating disease with inadequate treatments.
Baxter International Inc. and Nycomed today announced the U.S. Food and Drug Administration (FDA) approval of TachoSil (Absorbable Fibrin Sealant Patch) for use as an adjunct to hemostasis in cardiovascular surgery. TachoSil is the first and only adjunctive hemostatic agent available in the U.S. that combines a collagen patch with a coating of human coagulation factors.
SARS-CoV-2 pandemic has highlighted the shortcomings in emergency response globally and has driven a massive demand for in vitro diagnostic testing technologies. In order to address these issues, researchers from the US recently used the new pH dye LAMPShade Violet (LSV) in RT-LAMP. LSV has better visual contrast between high and low pH and a stronger inflection point, both of which enable easy interpretation of results and reduces ambiguity.
Methylphenidate is a drug commonly prescribed for attention deficit hyperactivity disorder (ADHD) in children. The rapid increase in use of the drug over the past few decades has been noted in numerous countries, including Canada.
In light of the recent recommendation of the United States Preventative Task Force (USPTF), the Obesity Action Coalition (OAC) is calling for all employers and insurers to add health insurance coverage of the recommended childhood obesity treatments.
› Verified 7 days ago
Dr. Jerrod Tyler Heermans, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 350 Heritage Way Ste 2300, Kalispell, MT 59901 Phone: 406-890-7432 Fax: 406-890-7402 | |
Sarabeth Lee Martin, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 350 Heritage Way Ste 2300, Kalispell, MT 59901 Phone: 406-890-7432 | |
Dr. Gregory Thomas Adams, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 350 Heritage Way, 2300, Kalispell, MT 59901 Phone: 406-752-8456 Fax: 406-755-1088 | |
Amy K Mckerrow, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 350 Heritage Way, Suite 2300, Kalispell, MT 59901 Phone: 406-752-8456 Fax: 406-752-1443 | |
John D Andenoro, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 350 Heritage Way Ste 2300, Kalispell, MT 59901 Phone: 406-752-8456 Fax: 406-752-1443 | |
Michael J Berson, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 169 Sunset Trl, Kalispell, MT 59901 Phone: 406-257-6888 | |
Dr. Craig Grinnell Hinman, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 625 7th Ave E, Kalispell, MT 59901 Phone: 509-590-6827 |